Wednesday 27th November 2013
|Text too small?|
Shares in SeaDragon, which manufactures fish oils for health supplements, dropped 39 percent after the company sold shares at a discount to raise capital for a new $4 million factory near Richmond.
Shares in SeaDragon dropped 1.4 cents to 2.2 cents. After the market closed yesterday, the Auckland-based company agreed to issue 125 million new shares at 1.6 cents apiece, raising $2 million. The funds, combined with $1.8 million from the sale of a stake in Snakk Media will enable the company to proceed with its new factory.
SeaDragon is investing in a new factory to allow it to diversify from its current production of squalene and shark liver oil products and ramp up production of higher value Omega-3 fish oils from Hoki, Tuna and Salmon, enabling it to grow its share of the US$30 billion market for fortified foods and drinks.
"Worldwide demand for Omega-3 rich fish oil is growing rapidly supported by a compelling body of scientific literature on the human health benefits of Omega-3 rich diets," chairman Doug Wilson said in a statement. "SeaDragon's new refined fish oil plant will allow the company to take advantage of this opportunity and ensure we can meet demand well into the future."
SeaDragon, the largest producer of refined fish oils in Australasia, exports about three quarters of its products. The company expects to complete its new factory on the outskirts of Richmond in the fourth quarter of 2014 and will likely move production of shark liver oil, squalene and krill oil from its Nelson site when the current lease expires.
The company's base in Nelson allows it access to Hoki fisheries as well as Salmon farmed in the Marlborough Sounds. Oil from both species are rare and can attract a premium over the anchovy oils that dominate the Omega-3 fish oil market, the company said.
SeaDragon said it also plans to offer shareholders the opportunity to buy as much as $15,000 of its shares at the same price as the share placement. The company today reiterated that it is unlikely to meet its earnings forecasts because of a delay in commissioning the new plant, which had previously been slated for completion in August 2014.
The company's shares have gained 33 percent this year, taking its market capitalisation to $53.3 million.
No comments yet
RBNZ a 'poor communicator' - CBL's Harris
Methane reduction target could be catastrophic - Fonterra Shareholders' Council
Greater role for gas in electrification of transport, industry
Chorus sees growth in high value gigabit fibre plans
Arvida gets 87% uptake in $92 mln rights offer
NZ dollar weakens after US retail sales boost greenback
17th July 2019 Morning Report
Dairy product prices gain for first time in five auctions
MARKET CLOSE: NZ shares fall in listless trading; power companies gain
Gold Report 16th July 2019